Interestingly, the latest subclassification of DLBCL contains a cluster of human B-cell lymphomas, driven by deregulated methyl transferases, such as EZH2 or MLL4 [54,87], that often occur together with MYC and BCL-2 alterations. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.